Published in Minerva Urol Nefrol on December 01, 1999
Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg (1994) 2.05
Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity. Eur J Neurol (2011) 1.50
Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings. Ann Oncol (2011) 1.34
Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. Eur J Cancer (2011) 1.29
First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma. Ann Oncol (2008) 1.18
Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. A randomized single-blind study. Am J Clin Oncol (1991) 1.10
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial. Br J Cancer (2011) 1.08
Open prostatectomy in benign prostatic hyperplasia: 10-year experience in Italy. Eur Urol (1998) 1.08
Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin. J Urol (2001) 1.07
Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales. Ann Oncol (1991) 1.06
Intermittent catheterization with a prelubricated catheter in spinal cord injured patients: a prospective randomized crossover study. J Urol (2001) 0.96
A pilot study of metoclopramide, dexamethasone, diphenhydramine and acupuncture in women treated with cisplatin. Cancer Chemother Pharmacol (1990) 0.93
Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis. Br J Cancer (2013) 0.91
Colposacropexy with Gore-tex mesh in marked vaginal and uterovaginal prolapse. Eur Urol (1998) 0.89
Rhabdomyosarcoma of spermatic cord in adult. Urology (1982) 0.87
High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer. Eur J Cancer (1993) 0.87
Incidentally detected renal cell carcinoma: role of ultrasonography. J Clin Ultrasound (1992) 0.87
Masturbation injury resulting from intraurethral introduction of spaghetti. Am J Forensic Med Pathol (1986) 0.87
Xanthogranulomatous pyelonephritis: clinical experience with 62 cases. Eur Urol (1986) 0.86
Penile prosthesis implantation and couple's satisfaction. Urol Int (1999) 0.86
Four-corner colposuspension: clinical and functional results. Int Urogynecol J Pelvic Floor Dysfunct (2003) 0.84
Biofeedback successfully cures detrusor-sphincter dyssynergia in pediatric patients. J Urol (2000) 0.84
New therapeutic options for refractory neurogenic detrusor overactivity. Minerva Urol Nefrol (2004) 0.84
Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial. Ann Oncol (2013) 0.83
Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium hyaluronic acid-chondroitin sulphate (Ialuril®). Urol Int (2013) 0.83
Renal cell carcinoma: histological findings on surgical margins after nephron sparing surgery. J Urol (2003) 0.82
Is maize B chromosome preferential fertilization controlled by a single gene? Heredity (Edinb) (2001) 0.82
Intrinsic sphincter deficiency: do the maximum urethral closure pressure and the Valsalva leak-point pressure identify different pathogenic mechanisms? Int Urogynecol J Pelvic Floor Dysfunct (2002) 0.82
Surgical repair of ureteral defects. Ital J Surg Sci (1983) 0.81
A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN. Ann Oncol (2013) 0.81
Laparoscopic treatment of colovesical fistulas due to complicated colonic diverticular disease: a systematic review. Tech Coloproctol (2014) 0.80
Extracellular matrix degrading enzymes at the prostasome surface. Prostate Cancer Prostatic Dis (2005) 0.80
Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis. Eur J Cancer (1991) 0.80
[Milk of calcium renal stone: echographic diagnosis]. Arch Ital Urol Androl (1996) 0.79
Peyronie's disease: corporoplasty using saphenous vein patch graft. Urol Int (2002) 0.79
Differing expression of enzymes of the glyoxalase system in superficial and invasive bladder carcinomas. Eur J Cancer (2002) 0.79
Are post-docetaxel treatments effective in patients with castration-resistant prostate cancer and performance of 2? A meta-analysis of published trials. Prostate Cancer Prostatic Dis (2013) 0.79
Conservative surgery and quality of life in a young patient with synchronous bilateral embryonal carcinoma. Eur Urol (1996) 0.78
Extracorporeal piezoelectric shockwave lithotripsy of ureteral stones: are second-generation lithotripters obsolete? J Endourol (1999) 0.78
Renal cell carcinoma with synchronous adrenal metastases. Acta Urol Belg (1990) 0.77
Surgical treatment of renovascular hypertension secondary to renal trauma. J Urol (1981) 0.77
The effects of prolonged cardiopulmonary bypass on cell-mediated immunity. Thorac Cardiovasc Surg (1994) 0.77
Effects of a continuous diltiazem infusion on renal function during cardiac surgery. J Cardiothorac Vasc Anesth (1993) 0.77
Ondansetron (GR38032) in the prophylaxis of acute and delayed cisplatin-induced emesis. Clin Oncol (R Coll Radiol) (1990) 0.77
Urethral syndrome: clinical results with antibiotics alone or combined with estrogen. Eur Urol (1994) 0.76
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis. Ann Oncol (2015) 0.76
Localization of the genes controlling B chromosome transmission rate in maize (Zea mays ssp. mays, Poaceae). Am J Bot (1998) 0.76
Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study. Cancer (2000) 0.76
Myxoid liposarcoma of the bladder. J Urol (1983) 0.76
Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma. J Endocrinol Invest (2012) 0.76
Molecular mechanism of myoglobin autoxidation: insights from computer simulations. J Phys Chem B (2015) 0.76
Intralesional alpha interferon therapy in papillary superficial transitional cell carcinoma of the bladder. A pilot study. Br J Urol (1993) 0.76
A double-blind trial comparing antiemetic efficacy and toxicity of metoclopramide versus methylprednisolone versus domperidone in patients receiving doxorubicin chemotherapy alone or in combination with other antiblastic agents. Am J Clin Oncol (1988) 0.75
A pilot study of metoclopramide, dexamethasone, diphenhydramine and lorazepam in prevention of nausea and vomiting in cisplatin-treated male patients. Oncology (1990) 0.75
Diuretic ultrasound. A non-invasive technique for the assessment of upper tract obstruction. Br J Urol (1990) 0.75
Ureteral endometriosis: an endoscopic diagnosis. Urology (1985) 0.75
[Clinical considerations of intradiverticular bladder neoplasms]. Acta Urol Belg (1984) 0.75
Reliability and validity of a quality of life questionnaire in cancer patients. Eur J Cancer (1993) 0.75
Ondansetron. Eur J Cancer (1993) 0.75
[Chemotherapy of prostate cancer: potential role of docetaxel]. Tumori (2002) 0.75
Prostatic abscess. Diagnosis and follow-up. Acta Urol Belg (1986) 0.75
Stage pT1 renal cell carcinoma: review of the prognostic significance of size. Urol Int (2003) 0.75
[Echo-guided percutaneous drainage of renal cysts]. Arch Ital Urol Androl (1993) 0.75
[Echographic features of testicular neoplasms. Our experience]. Arch Ital Urol Androl (1994) 0.75
[Echographic follow-up after radical prostatectomy]. Arch Ital Urol Androl (1996) 0.75
[Urethral diverticuli in women: role of diagnostic methods in the preoperative assessment]. Arch Ital Urol Androl (1994) 0.75
Inflammatory reaction presages response in melanoma skin lesions during i.m. rIFN alpha-2a-based treatment. Ann Oncol (1990) 0.75
Ureterointestinal anastomosis in orthotopic neobladders. Urol Int (2000) 0.75
[Effect of piperazine in a citrosodic vehicle on urinary pH in uric acid lithiasis]. Minerva Urol (1980) 0.75
Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients. Am J Clin Oncol (1992) 0.75
Ultrasound monitoring of prostatic cancer in treatment. Prog Clin Biol Res (1987) 0.75
[Therapeutic efficacy of mepartricin in the medical treatment of prostatic hypertrophy]. Minerva Med (1986) 0.75
Antiemetic therapy in patients treated with cisplatin chemotherapy. J Chemother (1989) 0.75
[Role of ultrasonography in the follow-up of surgically treated patients. Upper urinary tract. Complications after conservative surgery]. Arch Ital Urol Nefrol Androl (1992) 0.75
Quality of life studies and genito-urinary tumors. Ann Oncol (2001) 0.75
Renal cell carcinoma: histological findings in peritumoral tissue after organ-preserving surgery. Eur Urol (1996) 0.75
Real-time transrectal sonographic voiding cystourethrography. Urology (1987) 0.75
[Cystic renal pathology]. Arch Ital Urol Androl (1993) 0.75
[Carcinoma of the prostate: correlation between local staging and systemic progression]. Arch Ital Urol Androl (1996) 0.75
Unusual association of renal carcinoma and transitional cell carcinoma of the contralateral pelvis. Diagnostic aspects and therapeutical management. Acta Urol Belg (1988) 0.75
Feminine urinary incontinence and urodynamic examination. Clin Exp Obstet Gynecol (1981) 0.75
The role of chemotherapy in the treatment of prostatic carcinoma. Rays (1993) 0.75
[Locally advanced prostatic cancer and systemic involvement]. Arch Ital Urol Androl (1994) 0.75